60 likes | 151 Views
The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy.
E N D
Viscosupplementation - 5EU Analysis and Market Forecasts By RnRMarketResearch.com Publisher Name : GlobalData Date: 10-Jul-2015 Single User License: US $4450 Browse more Reports on Orthopedic Device at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/orthopedic-device . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Viscosupplementation - 5EU Analysis and Market Forecasts The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy. However, there is a growing concern among physicians that the updated American Academy of Orthopaedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will result in increased insurance denials for viscosupplementation. Moving forward, industry consolidation and intense competition in the viscosupplementation arena will cause increasing numbers of companies to augment their research efforts to differentiate their products from the lower-end competitors. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Viscosupplementation - 5EU Analysis and Market Forecasts Companies Discussed/Mentioned in this Research: Anika Therapeutics, Ferring Pharmaceuticals, FidiaFarmaceutici S.p.A., Meda AB, Sanofi, Seikagaku Corporation, Bioventus, DePuySynthes and Zimmer-Biomet Explore More Research Report on Orthopedic Devices Market. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Viscosupplementation - 5EU Analysis and Market Forecasts Key Questions Answered - • Future growth in the viscosupplementation market lies in the one-injection segment. What are the current adoption trends in different geographies? How will one-injection segment drive the market revenue growth in the upcoming years? • Reimbursement is the single greatest barrier to the market growth for viscosupplementation procedures. How does the current payer mix look like in different countries? • In recent years, there has been an expansion in the use of intra-articular HA viscosupplementation for treating OA at hips, shoulders, and other small joints. What are the current adoption trends in different regions? • Because the most prevalent treatment regimen varies from region to region, the competitive landscape in the viscosupplementation space can be quite different across the geographies covered in this report. Who are the leading players in the viscosupplementation market in different countries? ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Viscosupplementation - 5EU Analysis and Market Forecasts Reasons to Buy: • "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. Request a sample –http://www.rnrmarketresearch.com/contacts/request-sample?rname=423733 . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Viscosupplementation - 5EU Analysis and Market Forecasts For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441